Quote · The Peter Attia Drive
#392 - Genetic testing: when it's valuable, how to choose the right test, and what to do with the results
Where this was said
Framework summary: why genetic testing is most valuable when guided by a clear question, matched with the appropriate test, and capable of meaningfully influencing decisions
At 1:01:18 · chapter starts 56:45
In the closing section, Peter synthesizes the entire episode into a practical summary. He identifies three buckets. The best use case: BRCA and Lynch syndrome testing, where high penetrance meets clear actionability and the information can be genuinely life-saving. The worst use case: direct-to-consumer style panels testing low-effect common variants like MTHFR and COMT, which are then used to justify supplement protocols with no supporting clinical evidence. Most cases fall in the middle, where genetic information can be informative but is less clearly actionable or evidence-supported [1] — Peter Attia "Test with intention. Know what you're looking for. Know what you'll do when you find it out and know what you will do if you don't." 1:01:18 . Peter gives APOE4 its own special place: not highly actionable in the traditional sense, but valuable for risk stratification, motivating lifestyle adherence, and long-term planning. He acknowledges that seeking genetic information purely out of curiosity is not illegitimate, provided the person understands they may not gain more clarity. He closes with the principle that will define his approach to genetic testing: test with intention. Know what you're looking for. Know what you'll do when you find it. Know what you'll do if you don't. Everything else, he says, follows from that.
